TB

Publications

click to view chapters and sections

Disease Control Priorities in Developing Countries (2nd Edition)
  1. 62. Control and Eradication
  2. 55. Drug Resistance
    1. Agenda for Action
    2. Implementation of Strategies: Two Lessons from Experience
    3. Interventions
    4. Risk Factors
  3. 72. Ensuring Supplies of Appropriate Drugs and Vaccines
    1. Issues for the Future
    2. Procurement of Drugs
    3. Selection of Drugs
    4. The WHO Prequalification Schemes
    5. Vaccine Research Priorities
  4. 12. Financing Health Systems in the 21st Century
    1. Health Financing Issues in LICs
    2. Health Financing Systems
  5. 8. Improving the Health of Populations: Lessons of Experience
    1. Cases
  6. 2. Intervention Cost–Effectiveness: Overview of Main Messages
    1. Discussion
  7. 1. Investing in Health
    1. Annex 1.A: The Burden of Disease in 2001
  8. 9. Millennium Development Goals for Health: What Will It Take to Accelerate Progress?
    1. Costing and Financing Additional Spending for the MDGs
  9. 60. Occupational Health
    1. Nature and Causes of Occupational Health Conditions in the Developing World
  10. 4. Priorities for Global Research and Development of Interventions
  11. 6. Product Development Priorities
    1. Diagnostics
    2. Financing and Institutional Arrangements for New Product Development
    3. Introduction
    4. Regulatory and Liability Issues
  12. 13. Recent Trends and Innovations in Development Assistance for Health
    1. Conclusions
    2. Making Development Assistance for Health More Effective: Lessons Learned
  13. 35. Respiratory Diseases of Adults
    1. Acute Diseases: Pneumonia and Influenza
    2. Chronic Respiratory Diseases: Nature, Causes, and Burden
    3. Future Research Needs
    4. General Approach to Lowering Risk of Adult Respiratory Disease
    5. Occupational Lung Disease and Other Respiratory Diseases
  14. 16. Tuberculosis
    1. Acknowledgments
    2. Alternative and Complementary Approaches to the Diagnosis and Treatment of Active Disease
    3. Conclusions
    4. Cost-Effectiveness of Interventions against Tuberculosis
    5. Cost-Effectiveness of Managing Endemic Tuberculosis
    6. Cost-Effectiveness of Managing Tuberculosis Outbreaks
    7. Epidemiological Burden and Trends
    8. Interventions against Tuberculosis
    9. Research and Development
    10. Summary of Cost-Effectiveness Analyses
    11. Tuberculosis Infection, Disease, and Death
  15. 20. Vaccine–Preventable Diseases
    1. Improving the Costs and Cost-Effectiveness of Immunization Programs
Global Burden of Disease and Risk Factors
  1. 3. The Burden of Disease and Mortality by Condition: Data, Methods, and Results for 2001
    1. Discussion and Conclusions
    2. Global and Regional Mortality in 2001
Priorities in Health
  1. 1. Accomplishments, Challenges, and Priorities
  2. 5. Cost–Effective Strategies for Noncommunicable Diseases, Risk Factors, and Behaviors
    1. Tobacco Use
  3. 4. Cost–Effective Strategies for the Excess Burden of Disease in Developing Countries
  4. 7. Pillars of the Health System
    1. Financing
    2. Human Resources
    3. Management of Health Services
  5. 6. Providing Interventions
  6. 2. Success in Addressing Priorities

Back to Full List of Topics

QUICK FIND

Find specific content in the three core DCPP publications.




EMAIL UPDATES

Sign up to receive periodic email updates from DCPP